Avaliação de nódulo pulmonar solitário

Última revisão: 12 Apr 2025
Última atualização: 24 Jan 2024

Resumo

Diagnósticos diferenciais

comuns

  • Hamartoma
  • Infecciosa
  • Câncer pulmonar primário
  • Câncer metastático
  • Linfonodo intrapulmonar
  • Sarcoidose
  • Artrite reumatoide
  • Granulomatose com poliangiite (anteriormente conhecida como granulomatose de Wegener)
Detalhes completos

Incomuns

  • Tumor carcinoide
  • Linfoma
  • Malformação arteriovenosa
  • Amiloidose pulmonar
  • Impactação mucoide
Detalhes completos

Colaboradores

Autores

Dr George Tsaknis, MD, PhD, FRCP(London), MRQA, MAcadMEd, PGCert

Honorary Senior Lecturer

Department of Respiratory Sciences

University of Leicester

Leicester

UK

Consultant in Respiratory Medicine and Lung Cancer Lead

Clinical Director

Lung Cancer Screening Programme

Kettering General Hospital

Kettering

UK

Declarações

GT declares that he has no competing interests.

Dr Harvinder Virk, MBChB (Hons), MA (Oxon), MRes, PhD, MRCP

NIHR Academic Clinical Lecturer in Respiratory Medicine

Department of Respiratory Sciences

University of Leicester

Leicester

UK

Declarações

HV declares that he has no competing interests.

Agradecimentos

Dr George Tsaknis and Dr Harvinder Virk would like to gratefully acknowledge Dr Peter J. Mazzone and Dr Erik E. Folch MD, previous contributors to this topic.

Declarações

PJM has been paid to participate in clinical advisory board meetings for Oncimmune, InDi, Nucleix, Grail, and Oncocyte, all companies interested in developing molecular biomarkers for the evaluation of lung nodules/lung cancer; he does not have a contractual agreement to disseminate product information for any of these companies. PJM has participated in research supported by InDi Veracyte, funding for which was paid to his institution. He has also participated in research with in-kind support from Oncimmune and 20/20 Genesystems. EEF is the global principal investigator for the NAVIGATE trial, sponsored by Medtronic. He has also served as scientific consultant for Boston Scientific in the development of advanced bronchoscopic techniques.

Revisores

Pallav L. Shah, MD, MBBS, FRCP

Consultant Physician

Royal Brompton Hospital

Chelsea & Westminster Hospital

London

UK

Declarações

PLS declares that he has no competing interests.

Sangeeta M. Bhorade, MD

Associate Professor of Medicine

Medical Director

Lung Transplant Program

University of Chicago Hospitals

Chicago

IL

Declarações

SMB declares that she has no competing interests.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

American College of Radiology. ACR appropriateness criteria​: incidentally detected indeterminate pulmonary nodule. 2023 [internet publication].Texto completo

Callister ME, Baldwin DR, Akram AR, et al. British Thoracic Society guidelines for the investigation and management of pulmonary nodules. Thorax. 2015 Aug;70 Suppl 2:ii1-54.Texto completo  Resumo

MacMahon H, Naidich DP, Goo JM, et al. Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner Society 2017. Radiology. 2017 Jul;284(1):228-43.Texto completo  Resumo

Gould MK, Donington J, Lynch WR, et al. Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013 May;143(5 Suppl):e93S-120.Texto completo  Resumo

Ruparel M, Quaife SL, Navani N, et al. Pulmonary nodules and CT screening: the past, present and future. Thorax. 2016 Apr;71(4):367-75.Texto completo  Resumo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.

O uso deste conteúdo está sujeito ao nosso aviso legal